ArticleCureus2025
Neurotoxic Effects of Tramadol Administration on the Cerebellar and Cerebral Cortices of Adult Male Wistar Rats.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Tramadol, a widely prescribed synthetic opioid, is commonly used for managing moderate to severe pain due to its dual mechanism of action as a μ-opioid receptor agonist and norepinephrine and serotonin reuptake inhibitor. Aim To evaluate the neurotoxic effects of tramadol administration on the cerebellar and cerebral cortices of adult male Wistar rats, focusing on behavioural changes, oxidative stress markers, and histopathological alterations. Materials and methods Twenty adult male Wistar rats were divided into four groups of five rats each: a control group and three treatment groups receiving 25 mg/kg, 50 mg/kg, and 75 mg/kg of tramadol orally, respectively, for 21 days. Physical behaviour was monitored. Oxidative stress markers were assessed. Histological examination of the cerebellum and cerebrum was also carried out. Results The tramadol-treated groups exhibited increased aggression and significant weight loss, particularly at higher doses. Oxidative stress markers showed no changes in the antioxidant enzymes assayed with the exception of catalase. Histopathological examination of the cerebellum showed intact cerebellar layers at the cortex with normal cellular structure and orientations for the control and treated group, while that of the cerebrum revealed mild morphological alterations in the cerebrum of tramadol-treated rats compared to the control group. Conclusion These findings suggest that tramadol exposure can lead to neurotoxic effects in the cerebrum of rats. The observed morphological and histological changes may contribute to the development of long-term adverse effects associated with tramadol use, such as cognitive impairment and mood disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.